رجوع

Kossan Rubber Industries Bhd

جودة البيانات: 100%

ذروة شراء

KSRBF

OTC Healthcare Medical - Instruments & Supplies

KWD 0.33

KWD 0.00 (0.00%)

القيمة السوقية: 841.70M

نطاق اليوم

KWD 0.33 KWD 0.33

نطاق 52 أسبوعًا

KWD 0.27 KWD 0.33

حجم التداول

1,000

متوسط 50 يوم / 200 يوم

KWD 0.33 / KWD 0.32

الإغلاق السابق

KWD 0.33

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس	السهم	وسيط القطاع
P/E	5.6	0.4
P/B	0.2	2.9
ROE %	4.1	3.7
Net Margin %	8.7	3.8
Rev Growth 5Y %	-28.4	10.0
D/E	0.0	0.2

النقاط الرئيسية

Revenue declined -28.39% annually over 5 years

Earnings grew 27.58% over the past year

ROE of 4.11% is below average

Debt/Equity of 0.02 — conservative balance sheet

Generating 51.75M in free cash flow

P/E of 5.58 — trading at a low valuation

النمو

Revenue Growth (5Y)

-28.39%

Revenue (1Y)-8.53%

Earnings (1Y)27.58%

FCF Growth (3Y)-33.10%

الجودة

Return on Equity

4.11%

ROIC2.63%

Net Margin8.66%

Op. Margin7.55%

الأمان

Debt / Equity

0.02

Current Ratio9.80

Interest Coverage94.74

التقييم

P/E Ratio

5.58

P/B Ratio0.23

EV/EBITDA-0.11

Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-8.53%	Revenue Growth (3Y)	4.70%
Earnings Growth (1Y)	27.58%	Earnings Growth (3Y)	236.45%
Revenue Growth (5Y)	-28.39%	Earnings Growth (5Y)	-52.04%
Profitability
Revenue (TTM)	1.74B	Net Income (TTM)	150.97M
ROE	4.11%	ROA	3.70%
Gross Margin	7.55%	Operating Margin	7.55%
Net Margin	8.66%	Free Cash Flow (TTM)	51.75M
ROIC	2.63%	FCF Growth (3Y)	-33.10%
Safety
Debt / Equity	0.02	Current Ratio	9.80
Interest Coverage	94.74	Dividend Yield	0.01%
Valuation
P/E Ratio	5.58	P/B Ratio	0.23
P/S Ratio	0.48	PEG Ratio	0.84
EV/EBITDA	-0.11	Dividend Yield	0.01%
Market Cap	841.70M	Enterprise Value	-14.78M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.74B	1.91B	1.59B	2.34B	6.63B
Net Income	150.97M	118.34M	13.34M	157.10M	2.85B
EPS (Diluted)	0.06	0.05	0.01	0.06	1.12
Gross Profit	131.68M	777.96M	640.55M	950.91M	4.60B
Operating Income	131.68M	114.40M	35.95M	184.51M	3.72B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	4.08B	4.09B	4.20B	4.33B	5.08B
Total Liabilities	359.52M	414.68M	339.32M	429.22M	1.02B
Shareholders' Equity	3.70B	3.65B	3.84B	3.88B	4.03B
Total Debt	63.31M	82.54M	17.34M	83.55M	251.80M
Cash & Equivalents	919.79M	974.11M	1.27B	1.35B	2.56B
Current Assets	2.25B	2.48B	2.80B	2.86B	3.58B
Current Liabilities	229.99M	293.92M	213.72M	284.75M	825.29M

درجات الاستراتيجيات

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)

Rank = position among all matches

Custom Deep Value Investing (Seth Klarman)

#737 of 820

Value Defensive Investing (Benjamin Graham)

#153 of 708

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)

Mar 24, 2026

دخل Defensive Investing (Benjamin Graham)

Mar 24, 2026